The 6 analysts offering 12-month price forecasts for Cogent Biosciences Inc have a median target of 21.00, with a high estimate of 28.00 and a low estimate of 18.00. The median estimate represents a +45.73% increase from the last price of 14.41.
The current consensus among 6 polled investment analysts is to Buy stock in Cogent Biosciences Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.51
Reporting Date Nov 14
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.